|
|
|
| Year |
Name |
Title |
| 2007-2009 |
Michael J. Englesbe, MD
University of Michigan
Ann Arbor, Michigan |
Seasonal Variation in Surgical Quality at Teaching and Non-Teaching Medical Centers in the United States |
| 2007-2009 |
Robert W. O'Rourke, MD
Oregon Health & Sciences University
Portland, Oregon |
Immunologic Function in Obese Bariatric Surgery Patients |
| 2007-2009 |
Christopher Wolfgang, MD
Johns Hopkins School of Medicine
Baltimore, Maryland |
Targeting Lipid Mediations of Pancreatic Cancer Growth |
| 2006-2008 |
Marc G. Jeschke, MD, PhD
Shriners Burns Hospital for Children
Galveston, Texas |
Insulin Administration Improves Hepatic Structure and Function via The P13K/Adt/Wnt/B-catenin |
| 2006-2008 |
Christopher E. Touloukian, MD
Indiana University
Indianapolis, Indiana |
Enhancing Tumor Immunity by Altering Systemic Antigen Expression |
| 2005-2007 |
Christopher K. Breuer, MD
Yale University School of Medicine
New Haven, Connecticut |
Investigating the Growth Potential of Tissue Engineered Venous Conduits in a Juvenile Lamb Model |
| 2005-2007 |
Nita Ahuja, MD
Johns Hopkins Hospital
Division of Surgical Oncology
Baltimore, Maryland |
Methylation Profiles in Colorectal Cancer-Utility in Prognosis and Diagnosis |
| 2004-2006 |
John F. Renz, M.D.
New York Presbyterian Hospital
Center for Liver Disease and Transplantation
New York, New York |
The Effect of Heat Shock Protein Expression Upon the Immunogenicity of Human Hepatocellular Carcinoma |
| 2004-2006 |
Shahab A. Akhter, M.D.
University of Cincinnati College of Medicine
Cincinnati, Ohio |
The role of the Beta-Adrenergic Receptor Kinase in the Development of Hypertrophic Cardiomyopathy |
| 2003-2005 |
Daniel A. Saltzman, M.D.
University of Minnesota
Minneapolis, Minnesota |
Mechanisms of Tumor Prevention for Attenuated Salmonella |
| 2003-2005 |
James C. Y. Dunn, M.D.
UCLA School of Medicine
Los Angeles, California |
Intestinal Tissue Engineering for the Treatment of Short Bowel Syndrome |
| 2002-2004 |
Christopher R. Mantyh, M.D.
Duke University Medical Center
Durham, North Carolina |
Neurogenic Mechanisms of Chronic Colitis |
| 2002-2004 |
Herbert Chen, M.D.
University of Wisconsin Hospital
Madison, Wisconsin |
Gastrointestinal Neuroendocrine Tumors: A Possible Therapeutic Role for the RAS/RAF Signal Transduction Pathway |
| 2001-2003 |
Michael S. Mulligan, M.D.
University of Washington
Seattle, Washington |
Role of Chemokines in Ischemia Reperfusion of Lung |
| 2001-2003 |
James S. Allan, M.D.
Massachusetts General Hospital
Boston, Massachusetts |
The Role of MHC Allopeptides and Indirect Allo-recognition in the Pathogenesis of Chronic Lung Rejection |
| 2000-2002 |
Gilbert R. Upchurch, Jr., M.D.
University of Michigan School of Medicine
Ann Arbor, Michigan |
Activation of Matix Metalloproteinases During Aneurysm Formation is Nitric Oxide Dependent |
| 2000-2002 |
Robert C. Gorman, M.D.
Hospital University of Pennsylvania
Philadelphia, Pennsylvania |
Surgery for Post-Infarction Left Ventricular Remodelling |
| 1999-2001 |
Vivian Gahtan, M.D.
Yale University School of Medicine
New Haven, Connecticut |
Molecular Basis of Vascular Smooth Muscle Cell Migration: Thrombospondin-1 as a Paradigm |
| 1998-2000 |
John A. Goss, M.D.
Baylor College of Medicine
Houston, Texas |
Infectious Tolerance and Its Role in Intrathymic Tolerance |
| 1997-1999 |
Michael S. Conte, M.D.
Brigham and Women's Hospital
Boston, Massachusetts |
Endothelial Restoration and Vascular Remodeling |
| 1996-1998 |
Bruce R. Rosengard, M.D.
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania |
Two-Way Cell Trafficking and Microchimerism: Mechanisms of Rejection and Tolerance in Response to Solid Organ and Cellular Transplants |
| 1994-1996 |
Ronald J. Weigel, M.D., Ph.D.
Stanford University School of Medicine
Stanford, California |
Transcriptional Regulation of Estrogen Receptor in Breast Carcinoma |
| 1992-1994 |
Jonathan S. Bromberg, M.D., Ph.D.
University of Michigan Medical Center
Ann Arbor, Michigan |
Anti-CD2 and Anti-CD3 Monoclonal Antibodies Synergize to Prolong Allograft Survival with Decreased Side Effects |
| 1990-1992 |
B. Mark Evers, M.D.
University of Texas Medical Branch
Galveston, Texas |
Effect of GI Hormones on Growth of Normal and Neoplastic Gut Tissue |
| 1988-1990 |
Lawrence Rosenberg, M.D.
Montreal General Hospital
Montreal, Quebec, CANADA |
Islet Cell Differentiation in the Hamster Pancreas |
| 1986-1988 |
Ronald G. Tompkins, M.D.
Massachusetts General Hospital
Boston, Massachusetts |
Hybrid Artificial Liver Using Gel Entrapped Hepatocytes |
| 1984-1986 |
Michael E. Shapiro, M.D.
Beth Israel Deaconess Medical Center
Boston, Massachusetts |
Immune Regulation of Intraabdominal Abscesses |
| 1982-1984 |
Dana K. Andersen, M.D.
Yale University School of Medicine
New Haven, Connecticut |
Studies on the Pathophysiologic Role of Gastric Inhibitory Polypeptide (GIP) in Medically and Surgically Induced Changes in Glucose Metabolism |
